SLU’s vaccine center awarded $2.9 million to study new TB vaccine

ST. LOUIS -- Saint Louis University's Center for Vaccine Development has received a $2.9 million award from the Bill & Melinda Gates Foundation to study a new tuberculosis vaccine.